Alzheimer's drug lecanemab hailed as momentous breakthrough

 

 

The first drug to slow the destruction of the brain in Alzheimer's has been heralded as momentous.

The research breakthrough ends decades of failure and shows a new era of drugs to treat Alzheimer's - the most common form of dementia - is possible.

Yet the medicine, lecanemab, has only a small effect and its impact on people's daily lives is debated.

And the drug works in the early stages of the disease, so most would miss out without a revolution in spotting it.

Lecanemab attacks the sticky gunge - called beta amyloid - that builds up in the brains of people with Alzheimer's.

 

Full story from BBC

 

Excellent news.

 

 

there is another drug approved earlier by fda in the USA.

But might give serious side affects, so might not become widely available

https://www.alz.org/alzheimers-dementia/treatments/aducanumab